Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS’ 2nd Phase 3 Trial
[ad_1] MAPS Public Benefit Corporation (MAPS PBC), the non-profit’s private biopharma leg developing psychedelic medicines, announced positive results from MAPP2, the company’s second Phase 3 study assessing MDMA-assisted therapy for…